SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States.
Diagn Microbiol Infect Dis
; 101(3): 115468, 2021 Nov.
Article
en En
| MEDLINE
| ID: mdl-34425451
ABSTRACT
Nasal and nasopharyngeal swab specimens tested by the Cepheid Xpert Xpress SARS-CoV-2 were analyzed by whole-genome sequencing based on impaired detection of the N2 target. Each viral genome had at least one mutation in the N gene, which likely arose independently in the New York City and Pittsburgh study sites.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Proteínas de la Nucleocápside de Coronavirus
/
SARS-CoV-2
/
COVID-19
Tipo de estudio:
Diagnostic_studies
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Diagn Microbiol Infect Dis
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos